Page last updated: 2024-08-26

propionylcarnitine and Heart Failure

propionylcarnitine has been researched along with Heart Failure in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (66.67)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M1
Andreadou, I; Cicchitelli, G; Ferrari, R; Guardigli, G; Merli, E1
Apstein, CS; Brenner, DA; Koh, SG; Korzick, DH; Saupe, KW; Tickerhoof, MM1
Dhalla, NS; Ferrari, R; Sethi, R; Wang, X1
Boni, L; D'Ambrosio, G; Iliceto, S; Marangelli, V; Rizzon, P; Scrutinio, D1
Ferrari, R1
De Giuli, F; Ferrari, R1
Anand, I; Chandrashekhan, Y; Confortini, R; De Giuli, F; Ferrari, R; Mazzoletti, A; Pasini, E1
Dhalla, KS; Dhalla, NS; Ferrari, R; Ganguly, PK; Sethi, R1
Lingetti, M; Mancini, M; Nolfe, G; Rengo, F; Sorrentino, GP1
Latte, S; Lizzadro, A; Mastursi, M; Nolfe, G; Pucciarelli, G; Sacra, C; Setaro, A1

Reviews

3 review(s) available for propionylcarnitine and Heart Failure

ArticleYear
Metabolic support for the heart: complementary therapy for heart failure?
    European journal of heart failure, 2016, Volume: 18, Issue:12

    Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine

2016
Metabolic modulation and optimization of energy consumption in heart failure.
    The Medical clinics of North America, 2003, Volume: 87, Issue:2

    Topics: Acetanilides; Cardiac Pacing, Artificial; Cardiotonic Agents; Carnitine; Energy Metabolism; Heart Failure; Humans; Piperazines; Ranolazine; Trimetazidine

2003
The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.
    Journal of cardiac failure, 1997, Volume: 3, Issue:3

    Topics: Animals; Cardiotonic Agents; Carnitine; Chronic Disease; Disease Models, Animal; Heart; Heart Failure; Humans; Models, Biological; Muscles; Rabbits; Rats

1997

Trials

4 trial(s) available for propionylcarnitine and Heart Failure

ArticleYear
Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure.
    Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:3

    Topics: Adult; Cardiotonic Agents; Carnitine; Echocardiography; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Hormones; Humans; Male; Middle Aged; Neurosecretory Systems; Oxygen Consumption; Single-Blind Method; Time Factors; Ventricular Function

1998
Study on propionyl-L-carnitine in chronic heart failure.
    European heart journal, 1999, Volume: 20, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Carnitine; Chronic Disease; Diuretics; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Quality of Life; Retrospective Studies; Stroke Volume; Survival Rate; Treatment Outcome

1999
Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure.
    Arzneimittel-Forschung, 1992, Volume: 42, Issue:9

    Topics: Aged; Carnitine; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Ultrasonography

1992
[The clinical and hemodynamic effects of propionyl-L-carnitine in the treatment of congestive heart failure].
    La Clinica terapeutica, 1992, Volume: 141, Issue:11

    Topics: Aged; Cardiotonic Agents; Carnitine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1992

Other Studies

5 other study(ies) available for propionylcarnitine and Heart Failure

ArticleYear
Exercise intolerance during post-MI heart failure in rats: prevention with supplemental dietary propionyl-L-carnitine.
    Cardiovascular drugs and therapy, 2003, Volume: 17, Issue:1

    Topics: Animals; Carnitine; Diet; Disease Models, Animal; Exercise Tolerance; Heart Failure; In Vitro Techniques; Myocardial Infarction; Rats; Rats, Inbred F344; Tissue Distribution; Ventricular Function, Left

2003
Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction.
    Coronary artery disease, 2004, Volume: 15, Issue:1

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Carnitine; Disease Models, Animal; Enzyme Activation; GTP-Binding Proteins; Heart Failure; Isoproterenol; Male; Models, Cardiovascular; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Signal Transduction; Stroke Volume; Ventricular Function

2004
[The Italian contribution to the application of high-technology methods to clinical trials].
    Cardiologia (Rome, Italy), 1993, Volume: 38, Issue:12 Suppl 1

    Topics: Cardiology; Carnitine; Clinical Trials as Topic; Computer Communication Networks; Echocardiography; Heart Failure; Humans; Italy; Medical Laboratory Science; Myocardial Infarction; Software

1993
[Metabolism and function of peripheral muscles in heart failure: pharmacologic effects].
    Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:12 Suppl 1

    Topics: Cardiotonic Agents; Carnitine; Exercise; Heart Failure; Humans; Muscle, Skeletal; Regional Blood Flow

1995
Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction.
    Cardiovascular research, 1999, Volume: 42, Issue:3

    Topics: Adenylyl Cyclases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Carnitine; Heart Failure; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcolemma; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase; Time Factors; Ventricular Dysfunction, Left

1999